In NSCLC, activation of the DNA damage sensoring kinase Atr was decreased, whereas Axl inhibition in TNBC interfered with c-Myc levels and diminished levels of Atm in HNSCC [77]. The gene discussed is AXL; the disease is head and neck squamous cell carcinoma.